Aligos Therapeutics Stock (NASDAQ: ALGS) stock price, news, charts, stock research, profile.
You can purchase shares of Aligos Therapeutics (NASDAQ:ALGS) through any online brokerage.
Other companies in Aligos Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Galectin Therapeutics (NASDAQ:GALT), Monopar Therapeutics (NASDAQ:MNPR), PepGen (NASDAQ:PEPG) and Atossa Therapeutics (NASDAQ:ATOS).
Aligos Therapeutics has a consensus price target of $19.80.
The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $40.3388 last updated December 20, 2024 at 6:36 PM EST.
There are no upcoming dividends for Aligos Therapeutics.
Aligos Therapeutics’s Q4 earnings are confirmed for Tuesday, March 11, 2025.
There is no upcoming split for Aligos Therapeutics.
Aligos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.